CN102839205A - Method for preparing oligopeptide epidermis cell growth factor dry powder - Google Patents

Method for preparing oligopeptide epidermis cell growth factor dry powder Download PDF

Info

Publication number
CN102839205A
CN102839205A CN2012102980096A CN201210298009A CN102839205A CN 102839205 A CN102839205 A CN 102839205A CN 2012102980096 A CN2012102980096 A CN 2012102980096A CN 201210298009 A CN201210298009 A CN 201210298009A CN 102839205 A CN102839205 A CN 102839205A
Authority
CN
China
Prior art keywords
cell growth
growth factor
dry powder
oligopeptides
epithelical cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012102980096A
Other languages
Chinese (zh)
Inventor
任杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012102980096A priority Critical patent/CN102839205A/en
Publication of CN102839205A publication Critical patent/CN102839205A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for preparing oligopeptide epidermis cell growth factor dry powder includes a step of mixing proteases of different activities with part of additives according to a ratio; a step of putting mixed composite proteases into a polypeptide epidermis cell growth factor solution according to an actually required ratio and stirring the solution until the mixed composite proteases are dissolved well; a step of putting the mixed liquid into a liquid container, putting the liquid container into warm water, stirring the mixed liquid slightly, taking out the liquid container and putting the liquid container at room temperature after 20 minutes; a step of putting the liquid container into a vacuum extraction device for drying and extraction of the mixed liquid; and a step of putting the dry powder obtained from extraction into a bottle, sealing the bottle and preserving the dry powder at low temperature for later use. By means of the method, the molecular weight of obtained oligopeptide epidermis cell growth factors is far smaller than gaps of a skin cuticle, the oligopeptide epidermis cell growth factors are enabled to penetrate the gaps of the skin cuticle, enter the skin and play a good role in skin protection, and therefore the method for preparing the oligopeptide epidermis cell growth factor dry powder has good application prospects in the field of skincare and skin protection.

Description

A kind of method of making oligopeptides epithelical cell growth factor dry powder
Technical field
The present invention relates to the beauty and skin care field, specifically relate to a kind of method of making oligopeptides epithelical cell growth factor dry powder.
Background technology
Epithelical cell growth factor is the intravital a kind of protein and peptide material of people, and its maximum characteristics are to impel the propagation and the differentiation of epidermic cell, thereby replaces old and feeble with dead cell with new life's cell.The late nineteen eighties; Along with engineered development; People utilize the fast characteristics of growth and breeding such as intestinal bacteria and yeast to carry out industrial fermentation production, and use recombinant gene to produce this proteinoid peptide material identical with the human epidermal ESC.All the time, although epithelical cell growth factor effect aspect the healing of various skin wounds and operation is remarkable, practical function is limited in the beauty and skin care field.Trace it to its cause, still because the molecular weight of epithelical cell growth factor excessive (60KD~150KD), can't smooth transdermal stratum corneum gap (below the 10KD) due to.
Summary of the invention
The objective of the invention is to above-mentioned existing problems and deficiency; Provide a kind of manufacture craft simple, can easily the polypeptide epithelical cell growth factor be made into the method for the manufacturing oligopeptides epithelical cell growth factor dry powder of the oligopeptides epithelical cell growth factor that can see through the skin keratin lamellar spacing smoothly.
Technical scheme of the present invention is achieved in that
The method of manufacturing oligopeptides epithelical cell growth factor dry powder of the present invention is characterized in may further comprise the steps:
A, the proteolytic enzyme of different vigor is mixed with portions additive according to a certain percentage, then with the compound protease that mixes according to actual needs ratio put into and be stirred to dissolving fully in the polypeptide epithelical cell growth factor solution;
B, will dissolve mixed liquid and put in the liquid container and liquid container is placed 40 ℃~45 ℃ warm water, stir mixing liquid gently, and take out liquid container after 20 minutes and place room temperature;
C, liquid container put into the drying extraction of carrying out mixing liquid in vacuum freezing extraction plant or the vacuum microwave extraction plant;
D, will extract the dry powder that obtains after accomplishing and place sealing and for use certainly at low temperatures in the bottle, promptly accomplish the manufacturing of oligopeptides epithelical cell growth factor dry powder.
Wherein, the proteolytic enzyme of above-mentioned different vigor comprises papoid, bromeline.
Above-mentioned additive comprises dextrose anhydrous.
The ratio of above-mentioned compound protease that mixes and epithelical cell growth factor solution is 1:3000.
The proteolytic enzyme of above-mentioned different vigor and the ratio of additive are 1:10.
The molecular weight of above-mentioned oligopeptides epithelical cell growth factor dry powder is 0.5KD~3KD.
The invention has the beneficial effects as follows: through method of the present invention; Can easily the polypeptide epithelical cell growth factor be made into the oligopeptides epithelical cell growth factor; And the molecular weight of made oligopeptides epithelical cell growth factor is much smaller than the stratum corneum gap of skin; Thereby it can successfully transdermal stratum corneum gap be entered in the skin and play good skin care effect; Therefore it has a good application prospect in the beauty and skin care field, and manufacture craft of the present invention is simple, easy to operate, practical.
Embodiment
The method of manufacturing oligopeptides epithelical cell growth factor dry powder of the present invention may further comprise the steps:
At first; With the mixed that additives such as the proteolytic enzyme of these two kinds of different vigor of papoid and bromeline and dextrose anhydrous are pressed 1:10, the compound protease that mixes is put in the ratio of 1:3000 according to actual needs be stirred to dissolving fully in the polypeptide epithelical cell growth factor solution then;
Then, the mixed liquid of dissolving is put in the liquid container and with liquid container and placed 40 ℃~45 ℃ warm water, stir mixing liquid gently, take out liquid container after 20 minutes and place room temperature;
Then, put liquid container into carry out mixing liquid in vacuum freezing extraction plant or the vacuum microwave extraction plant drying extraction;
At last, the dry powder that obtains after the extraction completion is placed sealing and for use certainly at low temperatures in the bottle, promptly accomplish the manufacturing of oligopeptides epithelical cell growth factor dry powder, and the molecular weight of resulting oligopeptides epithelical cell growth factor dry powder is 0.5KD~3KD.
Through method of the present invention; Can easily the polypeptide epithelical cell growth factor be made into the oligopeptides epithelical cell growth factor; And since the molecular weight of made oligopeptides epithelical cell growth factor much smaller than the stratum corneum gap of skin; Thereby it can successfully transdermal stratum corneum gap be entered in the skin and play good skin care effect; Therefore it has a good application prospect in the beauty and skin care field, and manufacture craft of the present invention is simple, easy to operate, practical.
The present invention describes through embodiment; But the present invention is not constituted restriction, with reference to description of the invention, other variations of the disclosed embodiments; Professional person as for this area expects that easily such variation should belong within the scope thereof of the present invention.

Claims (6)

1. method of making oligopeptides epithelical cell growth factor dry powder is characterized in that may further comprise the steps:
A, the proteolytic enzyme of different vigor is mixed with portions additive according to a certain percentage, then with the compound protease that mixes according to actual needs ratio put into and be stirred to dissolving fully in the polypeptide epithelical cell growth factor solution;
B, will dissolve mixed liquid and put in the liquid container and liquid container is placed 40 ℃~45 ℃ warm water, stir mixing liquid gently, and take out liquid container after 20 minutes and place room temperature;
C, liquid container put into the drying extraction of carrying out mixing liquid in vacuum freezing extraction plant or the vacuum microwave extraction plant;
D, will extract the dry powder that obtains after accomplishing and place sealing and for use certainly at low temperatures in the bottle, promptly accomplish the manufacturing of oligopeptides epithelical cell growth factor dry powder.
2. according to the method for the said manufacturing oligopeptides of claim 1 epithelical cell growth factor dry powder, it is characterized in that the proteolytic enzyme of above-mentioned different vigor comprises papoid, bromeline.
3. according to the method for the said manufacturing oligopeptides of claim 1 epithelical cell growth factor dry powder, it is characterized in that above-mentioned additive comprises dextrose anhydrous.
4. according to the method for the said manufacturing oligopeptides of claim 1 epithelical cell growth factor dry powder, the ratio that it is characterized in that above-mentioned compound protease that mixes and epithelical cell growth factor solution is 1:3000.
5. according to the method for the said manufacturing oligopeptides of claim 1 epithelical cell growth factor dry powder, it is characterized in that the proteolytic enzyme of above-mentioned different vigor and the ratio of additive are 1:10.
6. according to the method for the said manufacturing oligopeptides of claim 1 epithelical cell growth factor dry powder, the molecular weight that it is characterized in that above-mentioned oligopeptides epithelical cell growth factor dry powder is 0.5KD~3KD.
CN2012102980096A 2012-08-21 2012-08-21 Method for preparing oligopeptide epidermis cell growth factor dry powder Pending CN102839205A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012102980096A CN102839205A (en) 2012-08-21 2012-08-21 Method for preparing oligopeptide epidermis cell growth factor dry powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012102980096A CN102839205A (en) 2012-08-21 2012-08-21 Method for preparing oligopeptide epidermis cell growth factor dry powder

Publications (1)

Publication Number Publication Date
CN102839205A true CN102839205A (en) 2012-12-26

Family

ID=47366923

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012102980096A Pending CN102839205A (en) 2012-08-21 2012-08-21 Method for preparing oligopeptide epidermis cell growth factor dry powder

Country Status (1)

Country Link
CN (1) CN102839205A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106727246A (en) * 2017-02-08 2017-05-31 上海元茵生物科技有限公司 Calf serum cell nutrient solution

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
姜国辉等: "重组人表皮生长因子透皮吸收实验研究", 《中国药学杂志》 *
陈秋东: "中等纯度重组人表皮生长因子(rhEGF)的分离纯化及在美容产品中的应用", 《中国优秀硕士学位论文全文数据库》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106727246A (en) * 2017-02-08 2017-05-31 上海元茵生物科技有限公司 Calf serum cell nutrient solution

Similar Documents

Publication Publication Date Title
CN102349867B (en) Water-replenishing repairing cosmetic as well as preparation method and application thereof
US20200040030A1 (en) Preparation of high purity collagen particles and uses thereof
CN104800146A (en) Skin-whitening and spot-erasing mask solution, preparation method thereof and skin-whitening and spot-erasing mask
CN106344427A (en) Polypeptide composition for facial care and preparation method of polypeptide composition
CN103393585B (en) Fibroblast liquid for beauty treatment and preparation method thereof
CN104814919A (en) Moisturizing anti-wrinkle mask solution, manufacturing method and moisturizing anti-wrinkle mask
CN101249043B (en) Applications of human growth hormone and human epidermal growth factor combination in beauty treatment
CN102796795A (en) Process method for quickly preparing soybean antioxidant peptide
CN105769653B (en) A kind of activity stabilized SOD skin care compositions and preparation method thereof
CN108486047A (en) A kind of medical dressing and preparation method thereof of stem cell extract
CN103266156A (en) Method for preparing deer blood protein peptide by using fractional enzymolysis technology
Rhee et al. Injectable tissue-engineered soft tissue for tissue augmentation
CN114159336A (en) Biological repair freeze-dried dressing capable of being rapidly dissolved and preparation method thereof
TWI630927B (en) Freeze-drying mixture powder of platelet rich plasma and human mesenchymal stem cell growth factors and the method for producing thereof
CN103479567A (en) Epidermal growth factor complex lipidosome, and preparation method and application of lipidosome
CN102839205A (en) Method for preparing oligopeptide epidermis cell growth factor dry powder
Han et al. Combining platelet-rich plasma and tissue-engineered skin in the treatment of large skin wound
CN107296781B (en) Snail facial mask containing snail protein powder and preparation method thereof
CN103830119A (en) Preparation method of toning lotion taking natural sericin as matrix
CN103462865B (en) Embryo water extract extracted from animal embryo skin and muscle, and extraction method and applications thereof
CN110840804A (en) Hirudin mask cream for removing freckles and eliminating scars and repairing and preparation method thereof
CN103320488B (en) Method for preparing ACE (Angiotensin Converting Enzyme) inhibitory peptides through proteolysis of eucommia seed cakes
CN101953757B (en) Freeze-dried gel cosmetic and preparation method and application thereof
CN116211891A (en) Human mesenchymal stem cell conditioned medium freeze-dried powder preparation and preparation method thereof
CN104739698A (en) Whitening and moisturizing essence and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121226